Thus, our findings unveil a novel mechanism implicated in tumor metastasis wherein the CDH4/β-catenin complex assumes an indispensable role, underscoring the potential of targeting CDH4 as a viable approach to modulate β-catenin in cancer therapy. The gene discussed is CDH4; the disease is neoplasm.